Adtalem Global Education (NYSE:CVSA) Shares Down 6.3% Following Insider Selling

Shares of Adtalem Global Education Inc. (NYSE:CVSA) fell 6.3% during mid-day trading on Monday following insider selling activity. The stock traded as low as $123.17 and last traded at $123.6040. 12,883 shares traded hands during trading, a decline of 97% from the average session volume of 368,967 shares. The stock had previously closed at $131.89.

Specifically, CEO Stephen W. Beard sold 2,529 shares of Adtalem Global Education stock in a transaction that occurred on Thursday, June 11th. The shares were sold at an average price of $130.78, for a total value of $330,742.62. Following the transaction, the chief executive officer directly owned 424,033 shares of the company’s stock, valued at $55,455,035.74. This trade represents a 0.59% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Stephen W. Beard sold 2,762 shares of Adtalem Global Education stock in a transaction dated Wednesday, June 10th. The shares were sold at an average price of $130.14, for a total value of $359,446.68. Following the completion of the transaction, the chief executive officer owned 426,562 shares in the company, valued at approximately $55,512,778.68. This represents a 0.64% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Analysts Set New Price Targets

Several research analysts have recently issued reports on CVSA shares. Barrington Research reiterated an “outperform” rating and set a $170.00 price target on shares of Adtalem Global Education in a report on Monday, June 8th. Zacks Research lowered shares of Adtalem Global Education from a “strong-buy” rating to a “hold” rating in a report on Wednesday, March 25th. Weiss Ratings reissued a “hold (c+)” rating on shares of Adtalem Global Education in a research note on Friday, May 22nd. Wall Street Zen upgraded Adtalem Global Education from a “hold” rating to a “buy” rating in a research report on Saturday. Finally, Truist Financial raised their target price on Adtalem Global Education from $130.00 to $140.00 and gave the stock a “buy” rating in a research note on Monday, May 11th. Two investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat, Adtalem Global Education presently has a consensus rating of “Moderate Buy” and a consensus target price of $155.00.

Adtalem Global Education Price Performance

The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.36. The company has a market cap of $4.25 billion, a price-to-earnings ratio of 19.40, a price-to-earnings-growth ratio of 1.07 and a beta of 0.62. The stock has a fifty day simple moving average of $120.70.

Adtalem Global Education (NYSE:CVSA) last announced its quarterly earnings data on Thursday, May 7th. The company reported $1.98 earnings per share for the quarter, beating the consensus estimate of $1.73 by $0.25. The firm had revenue of $487.03 million for the quarter. Adtalem Global Education had a net margin of 12.26% and a return on equity of 20.19%. Adtalem Global Education’s revenue for the quarter was up 4.5% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.92 EPS. Adtalem Global Education has set its FY 2026 guidance at 7.950-8.150 EPS. Equities research analysts expect that Adtalem Global Education Inc. will post 8.04 earnings per share for the current fiscal year.

About Adtalem Global Education

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.